- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Dicot Pharma AB: Dicot Pharma has resolved on an 80% guaranteed rights issue of approximately SEK 210 million | 472 | GlobeNewswire (Europe) | Uppsala, Sweden, May 8, 2026. The Board of Directors of Dicot Pharma AB ("Dicot Pharma" or the "Company") announced on April 28, 2026 its intention to resolve on a rights issue with preferential rights... ► Artikel lesen | |
| 06.05. | Dicot Pharma AB: Report from the Annual General Meeting of Dicot Pharma | 120 | GlobeNewswire (Europe) | Uppsala, Sweden, May 6, 2026. Dicot Pharma AB held its Annual General Meeting today in Uppsala where the following decisions were made.
Annual report and resultsThe meeting adopted the income statements... ► Artikel lesen | |
| DICOT PHARMA Aktie jetzt für 0€ handeln | |||||
| 30.04. | Dicot Pharma AB: Dicot Pharma presents interim report Q1 2026 and invites to a webcast | 133 | GlobeNewswire (Europe) | Uppsala, Sweden, April 30, 2026. Dicot Pharma AB publishes its interim report for the first quarter of 2026. The report is available as an attached document and on www.dicotpharma.com. The company will... ► Artikel lesen | |
| 28.04. | Dicot Pharma AB: Dicot Pharma intends to carry out an 80% already secured rights issue of SEK 210 million | 483 | GlobeNewswire (Europe) | Uppsala, Sweden, April 28, 2026. The Board of Directors of Dicot Pharma AB ("Dicot Pharma" or the "Company") intends to resolve on a rights issue of units, consisting of shares and warrants, corresponding... ► Artikel lesen | |
| 12.03. | Dicot Pharma AB: Dicot Pharma initiates tablet manufacturing ahead of phase 2b clinical study | 223 | GlobeNewswire (Europe) | Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcoming... ► Artikel lesen | |
| 18.12.25 | Dicot Pharma AB: Dicot Pharma signs agreement with CRO ahead of phase 2b study with LIB-01 | 466 | GlobeNewswire (Europe) | Uppsala, Sweden, December 18, 2025. Dicot Pharma AB has signed an agreement with a global contract research organization (CRO) to prepare for the planned phase 2b clinical study of the drug candidate... ► Artikel lesen | |
| 23.10.25 | Dicot Pharma AB: Dicot Pharma Announces Positive Results from its Phase 2a Study | 433 | GlobeNewswire (Europe) | Uppsala, Sweden October 23, 2025. Today, Dicot Pharma announces positive topline results from its phase 2a study of LIB-01 for the treatment of erectile dysfunction. The outcomes demonstrated clinically... ► Artikel lesen | |
| 27.08.25 | Dicot Pharma AB: Dicot Pharma included in global stock index | 403 | GlobeNewswire (Europe) | Uppsala, Sweden, August 27, 2025. As of today, the Swedish, erectile dysfunction drug developer Dicot Pharma has been incorporated into the MSCI Global Micro Cap Index, managed by MSCI, the world's... ► Artikel lesen | |
| 20.08.25 | Dicot Pharma AB: Dicot Pharma's Phase 2a study completed - results within three months | 370 | GlobeNewswire (Europe) | Uppsala, Sweden, August 20, 2025. Today, potency drug developer Dicot Pharma announces that the clinical part of its phase 2a study has been completed, as the final participant now has completed the... ► Artikel lesen | |
| 12.08.25 | Dicot Pharma AB: Dicot Pharma presents interim report Q2 2025 | 390 | GlobeNewswire (Europe) | Uppsala, Sweden, August 12, 2025. Dicot Pharma AB publishes its interim report for the second quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KHIRON LIFE SCIENCES | 0,029 | -100,00 % | Khiron Life Sciences Corp: Khiron Life Sciences warrants to expire Nov. 26 | ||
| CHRISTINA LAKE CANNABIS | 0,009 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,004 | +14,29 % | Psyched Wellness Ltd.: Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector | Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,004 | 0,00 % | XFRA C4T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGREENRISE GLOBAL... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,032 | -8,70 % | BetterLife Pharma Inc.: BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotech company, is pleased... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,048 | +6,67 % | Addex Therapeutics: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update | GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury... ► Artikel lesen | |
| MEDIPHARM LABS | 0,046 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA | Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1 2026 versus Q4 2025Company is virtually debt free, with a Q1 ending cash balance of $9.9... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,010 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Responds to Growing Demand for Muscle Health Support as Health Canada Expands Access to Semaglutide | Rejuvenate Muscle Health Adds Prominent GLP-1 Support Call-Out to New Packaging Set to Debut Later This Month Across North America; ECRM "Best Drink 2025" Validation; Promino NSF Certified for Sport... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,015 | 0,00 % | ARGENT BIOPHARMA LIMITED: Final Director's Interest Notice - GH | ||
| CANNABIST COMPANY | 0,020 | 0,00 % | Cannabist Co Holdings Inc. - 8-K, Current Report | ||
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Fiscal First Quarter 2026 Financial Results | NEW YORK and TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| CENTR BRANDS | 0,019 | 0,00 % | Centr Brands Corp (2): Centr Brands arranges $50,000 debenture financing | ||
| RESTART LIFE SCIENCES | 0,054 | -9,24 % | Restart Life Sciences Corp.: Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that... ► Artikel lesen | |
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen DICOT PHARMA AB kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,001 (+7,23 %) liegt der Kurs bei 0,018 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DICOT PHARMA AB finden Sie auf Wallstreet Online.